Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.36 USD | +3.11% | +7.83% | -5.03% |
05-08 | Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating | MT |
05-08 | Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.03% | 2.82B | |
+7.83% | 111B | |
+11.27% | 106B | |
-12.26% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.92% | 16.81B | |
+38.47% | 12.54B | |
-24.52% | 8.09B |
- Stock Market
- Equities
- DNLI Stock
- News Denali Therapeutics Inc.
- Insider Sell: Denali Therapeutics